Biotechnology

Low-Cost, Portable Biotech Tools Improve Access to Bior...

Using synthetic biology and cell-free systems, paired with low-cost hardware, re...

Attacking Gout: Crystalys Sees Room for Its Dotinurad a...

First-patient dosing in AMETHYST comes five days after a Crystalys rival, Swedis...

Organ Chips Move Towards Mainstream Drug Development, w...

From spaceflight to high-throughput studies, evidence supports greater use of or...

Targeted Protein Degradation Broadens Its Scope

Advancing targeted protein degradation (TPD) depends on a coordinated ecosystem ...

Pharma’s Trial Problem: Outdated Systems, Broken Data, ...

In this thought leadership article, Erik Terjesen of Silicon Foundry explores ho...

Top 10 U.S. Biopharma Clusters 2026

Mid-cap buyers, improved capital raising climate, and reshoring of manufacturing...

Turning the Patent Cliff into a Bioplant Opportunity

Using duckweed as an alternative to mammalian expression systems can ease manufa...

Neuropixels Opto Integrates Electrophysiology and Optog...

Neuropixels Opto is a single brain probe combining electrophysiology and optogen...

China has approved the world’s first invasive brain-com...

One day last October, sitting in the courtyard of his house in China’s Henan pro...

From Discovery to Development in Emerging Modalities

ProBio is building flexible platforms for multispecific antibodies, ADCs, and ot...

Multiomics Mass Spec Workflows in Drug Discovery

Advances in end-to-end multiomics platforms and the underlying scientific knowle...

Macrocyclic Peptide Drugs Unlocked, Membrane Permeabili...

A new method screens large libraries of synthetic cyclic peptides to identify co...

Mass Spectrometry’s Discovery Revolution

Next-generation MS platforms are transforming drug discovery by revealing comple...

Novel Therapeutic Modalities Target the Undruggable

Macrocycles, de novo antibodies, and mRNA therapies are expanding the drug disco...

The Confidence Gap: Why Drug Discovery’s Data Explosion...

In this thought leader piece Laurence Arnold, PhD, head of R&D at Pelago Bioscie...

Next Generation Biopharma Innovation

In a quest to provide more relevant translational data, traditional in vivo mode...